vs
礼来（RNA）与美国合众银行（SFBC）财务数据对比。点击上方公司名可切换其他公司
礼来的季度营收约是美国合众银行的1.3倍（$12.5M vs $9.5M），礼来同比增速更快（434.0% vs 1.5%），美国合众银行自由现金流更多（$7.0M vs $-156.9M），过去两年礼来的营收复合增速更高（138.5% vs 5.5%）
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业，在18个国家设有办事处，产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立，品牌名即取自创始人姓名。
美国合众银行是一家美国跨国银行机构，总部位于明尼苏达州明尼阿波利斯，在特拉华州注册成立。截至2025年，它是美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的金融机构，主营银行、投资、抵押贷款等相关金融服务。
RNA vs SFBC — 直观对比
营收规模更大
RNA
是对方的1.3倍
$9.5M
营收增速更快
RNA
高出432.5%
1.5%
自由现金流更多
SFBC
多$163.9M
$-156.9M
两年增速更快
RNA
近两年复合增速
5.5%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $12.5M | $9.5M |
| 净利润 | $-174.4M | — |
| 毛利率 | — | — |
| 营业利润率 | -1513.5% | 27.1% |
| 净利率 | -1398.3% | — |
| 营收同比 | 434.0% | 1.5% |
| 净利润同比 | -117.0% | — |
| 每股收益（稀释后） | $-1.27 | $0.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RNASFBC
| Q4 25 | — | $9.5M | ||
| Q3 25 | $12.5M | $9.8M | ||
| Q2 25 | $3.8M | $10.4M | ||
| Q1 25 | $1.6M | $9.2M | ||
| Q4 24 | $3.0M | $9.4M | ||
| Q3 24 | $2.3M | $9.1M | ||
| Q2 24 | $2.0M | $8.6M | ||
| Q1 24 | $3.5M | $8.6M |
净利润RNASFBC
| Q4 25 | — | — | ||
| Q3 25 | $-174.4M | $1.7M | ||
| Q2 25 | $-157.3M | $2.1M | ||
| Q1 25 | $-115.8M | $1.2M | ||
| Q4 24 | $-102.3M | — | ||
| Q3 24 | $-80.4M | $1.2M | ||
| Q2 24 | $-70.8M | $795.0K | ||
| Q1 24 | $-68.9M | $770.0K |
营业利润率RNASFBC
| Q4 25 | — | 27.1% | ||
| Q3 25 | -1513.5% | 21.3% | ||
| Q2 25 | -4448.7% | 24.5% | ||
| Q1 25 | -8360.9% | 15.9% | ||
| Q4 24 | -4069.6% | 24.6% | ||
| Q3 24 | -4200.9% | 15.6% | ||
| Q2 24 | -4040.4% | 11.4% | ||
| Q1 24 | -2178.6% | 10.9% |
净利率RNASFBC
| Q4 25 | — | — | ||
| Q3 25 | -1398.3% | 17.3% | ||
| Q2 25 | -4089.3% | 19.8% | ||
| Q1 25 | -7360.0% | 12.7% | ||
| Q4 24 | -3439.5% | — | ||
| Q3 24 | -3441.7% | 12.7% | ||
| Q2 24 | -3461.8% | 9.2% | ||
| Q1 24 | -1943.4% | 9.0% |
每股收益（稀释后）RNASFBC
| Q4 25 | — | $0.87 | ||
| Q3 25 | $-1.27 | $0.66 | ||
| Q2 25 | $-1.21 | $0.79 | ||
| Q1 25 | $-0.90 | $0.45 | ||
| Q4 24 | $-0.80 | $0.74 | ||
| Q3 24 | $-0.65 | $0.45 | ||
| Q2 24 | $-0.65 | $0.31 | ||
| Q1 24 | $-0.79 | $0.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $350.2M | $138.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.9B | $109.4M |
| 总资产 | $2.1B | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资RNASFBC
| Q4 25 | — | $138.5M | ||
| Q3 25 | $350.2M | $101.2M | ||
| Q2 25 | $243.9M | $102.5M | ||
| Q1 25 | $254.2M | $131.5M | ||
| Q4 24 | $219.9M | $43.6M | ||
| Q3 24 | $370.2M | $148.9M | ||
| Q2 24 | $575.8M | $135.1M | ||
| Q1 24 | $471.4M | $138.0M |
股东权益RNASFBC
| Q4 25 | — | $109.4M | ||
| Q3 25 | $1.9B | $107.5M | ||
| Q2 25 | $1.2B | $106.0M | ||
| Q1 25 | $1.3B | $104.4M | ||
| Q4 24 | $1.4B | $103.7M | ||
| Q3 24 | $1.5B | $102.2M | ||
| Q2 24 | $1.2B | $101.3M | ||
| Q1 24 | $830.9M | $101.0M |
总资产RNASFBC
| Q4 25 | — | $1.1B | ||
| Q3 25 | $2.1B | $1.1B | ||
| Q2 25 | $1.4B | $1.1B | ||
| Q1 25 | $1.5B | $1.1B | ||
| Q4 24 | $1.6B | $993.6M | ||
| Q3 24 | $1.6B | $1.1B | ||
| Q2 24 | $1.3B | $1.1B | ||
| Q1 24 | $951.5M | $1.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-156.2M | $7.2M |
| 自由现金流经营现金流 - 资本支出 | $-156.9M | $7.0M |
| 自由现金流率自由现金流/营收 | -1257.6% | 73.4% |
| 资本支出强度资本支出/营收 | 5.7% | 1.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-592.3M | $12.0M |
8季度趋势，按日历期对齐
经营现金流RNASFBC
| Q4 25 | — | $7.2M | ||
| Q3 25 | $-156.2M | $3.8M | ||
| Q2 25 | $-199.7M | $-494.0K | ||
| Q1 25 | $-124.8M | $1.9M | ||
| Q4 24 | $-99.9M | $2.9M | ||
| Q3 24 | $-65.6M | $3.3M | ||
| Q2 24 | $-65.0M | $-4.0M | ||
| Q1 24 | $-70.4M | $3.5M |
自由现金流RNASFBC
| Q4 25 | — | $7.0M | ||
| Q3 25 | $-156.9M | $3.8M | ||
| Q2 25 | $-203.0M | $-518.0K | ||
| Q1 25 | $-128.6M | $1.8M | ||
| Q4 24 | $-103.8M | $2.9M | ||
| Q3 24 | $-67.3M | $3.2M | ||
| Q2 24 | $-65.5M | $-5.6M | ||
| Q1 24 | $-71.3M | $1.9M |
自由现金流率RNASFBC
| Q4 25 | — | 73.4% | ||
| Q3 25 | -1257.6% | 38.3% | ||
| Q2 25 | -5277.1% | -5.0% | ||
| Q1 25 | -8174.3% | 19.8% | ||
| Q4 24 | -3491.0% | 30.4% | ||
| Q3 24 | -2881.8% | 35.5% | ||
| Q2 24 | -3204.6% | -65.4% | ||
| Q1 24 | -2012.3% | 22.2% |
资本支出强度RNASFBC
| Q4 25 | — | 1.8% | ||
| Q3 25 | 5.7% | 0.4% | ||
| Q2 25 | 86.9% | 0.2% | ||
| Q1 25 | 238.6% | 0.4% | ||
| Q4 24 | 131.7% | 0.8% | ||
| Q3 24 | 72.9% | 0.5% | ||
| Q2 24 | 26.0% | 18.7% | ||
| Q1 24 | 25.8% | 19.0% |
现金转化率RNASFBC
| Q4 25 | — | — | ||
| Q3 25 | — | 2.24× | ||
| Q2 25 | — | -0.24× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.84× | ||
| Q2 24 | — | -5.05× | ||
| Q1 24 | — | 4.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
